MannKind (MNKD) Revenue & Revenue Breakdown
MannKind Revenue Highlights
Latest Revenue (Y)
$198.96M
Latest Revenue (Q)
$19.73M
Main Segment (Y)
License and Service
MannKind Revenue by Period
MannKind Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $198.96M | 99.42% |
2022-12-31 | $99.77M | 32.25% |
2021-12-31 | $75.44M | 15.81% |
2020-12-31 | $65.14M | 3.34% |
2019-12-31 | $63.04M | 126.28% |
2018-12-31 | $27.86M | 137.20% |
2017-12-31 | $11.74M | -93.28% |
2016-12-31 | $174.76M | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | -100.00% |
2012-12-31 | $35.00K | -30.00% |
2011-12-31 | $50.00K | -46.24% |
2010-12-31 | $93.00K | 100.00% |
2009-12-31 | - | -100.00% |
2008-12-31 | $20.00K | 100.00% |
2007-12-31 | $10.00K | -90.00% |
2006-12-31 | $100.00K | 100.00% |
2005-12-31 | - | 100.00% |
2004-12-31 | - | 100.00% |
2003-12-31 | - | 100.00% |
2002-12-31 | - | -100.00% |
2001-12-31 | $326.00K | 111.69% |
2000-12-31 | $154.00K | - |
MannKind Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $19.73M | -72.75% |
2024-06-30 | $72.39M | 9.24% |
2024-03-31 | $66.26M | 13.32% |
2023-12-31 | $58.47M | 14.09% |
2023-09-30 | $51.25M | 5.43% |
2023-06-30 | $48.61M | 19.65% |
2023-03-31 | $40.63M | 12.67% |
2022-12-31 | $36.06M | 9.85% |
2022-09-30 | $32.83M | 73.73% |
2022-06-30 | $18.89M | 57.56% |
2022-03-31 | $11.99M | -4.18% |
2021-12-31 | $12.52M | -43.65% |
2021-09-30 | $22.21M | -4.59% |
2021-06-30 | $23.28M | 33.52% |
2021-03-31 | $17.44M | -5.46% |
2020-12-31 | $18.44M | 20.13% |
2020-09-30 | $15.35M | 1.57% |
2020-06-30 | $15.11M | -6.90% |
2020-03-31 | $16.23M | 1.51% |
2019-12-31 | $15.99M | 9.58% |
2019-09-30 | $14.60M | -2.71% |
2019-06-30 | $15.00M | -14.02% |
2019-03-31 | $17.45M | 8.83% |
2018-12-31 | $16.03M | 258.74% |
2018-09-30 | $4.47M | 14.80% |
2018-06-30 | $3.89M | 12.35% |
2018-03-31 | $3.46M | -23.51% |
2017-12-31 | $4.53M | 121.73% |
2017-09-30 | $2.04M | -5.55% |
2017-06-30 | $2.16M | -28.12% |
2017-03-31 | $3.01M | -75.74% |
2016-12-31 | $12.40M | -92.36% |
2016-09-30 | $162.35M | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | -100.00% |
2012-09-30 | $35.00K | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | -100.00% |
2011-03-31 | $50.00K | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | -100.00% |
2010-06-30 | $93.00K | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | 100.00% |
2008-06-30 | - | -100.00% |
2008-03-31 | $20.00K | 100.00% |
2007-12-31 | - | - |
MannKind Revenue Breakdown
MannKind Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
License and Service | $41.91M | - | - | - | - |
Product | - | $56.25M | $39.17M | $32.32M | - |
Royalty | - | $15.60M | - | - | - |
Service | - | $3.10M | - | - | - |
Product Sales | - | $81.07M | - | - | - |
License And Service | - | - | $22.02M | $9.56M | $7.90M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product | $19.73M | $17.44M | $16.26M | $12.72M | $9.83M | $11.34M | $9.75M | $10.06M | $7.28M | - | - | - | - | - | - | - | - | - | - | - |
License And Service | $23.27M | $14.78M | $10.68M | $8.71M | $7.14M | $6.08M | $5.51M | $3.29M | $2.63M | $1.58M | $1.98M | $3.36M | $2.39M | $1.84M | - | - | - | - | - | - |
Royalty | $27.08M | $9.07M | $6.22M | $304.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
License and Service | - | - | $22.64M | $10.26M | $9.01M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Service | - | - | - | - | - | - | $513.00K | $430.00K | $1.17M | - | - | - | - | - | - | - | - | - | - | - |
Product Sales | - | - | - | - | - | - | $26.47M | $26.18M | $17.42M | - | - | - | - | - | - | - | - | - | - | - |
Latest
MannKind Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BMRN | BioMarin Pharmaceutical | $2.42B | $733.87B |
UTHR | United Therapeutics | $2.33B | $748.90M |
TECH | Bio-Techne | $1.16B | $289.46M |
LEGN | Legend Biotech | $285.14M | $93.99M |
KNSA | Kiniksa Pharmaceuticals | $270.26M | $112.21M |
MNKD | MannKind | $198.96M | $19.73M |
SGMO | Sangamo Therapeutics | $176.23M | $356.00K |
ADAP | Adaptimmune Therapeutics | $60.28M | $128.23M |
LQDA | Liquidia | $17.49M | $4.45M |
AFMD | Affimed | $8.28M | $155.00K |
IMMP | Immutep | $3.51M | $2.11M |
SABS | SAB Biotherapeutics | $2.24M | $263.14K |
VSTM | Verastem | - | $10.00M |
INKT | MiNK Therapeutics | - | - |
PCVX | Vaxcyte | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ELEV | Elevation Oncology | - | - |
LRMR | Larimar Therapeutics | - | - |
ACER | Acer Therapeutics | - | $371.79K |
KTTA | Pasithea Therapeutics | - | - |